Since 1996, the National Glycohemoglobin Standardization Program has used calibration, certification, and proficiency testing initiatives to support labs nationwide in improving this crucial diabetes test.

One institute’s clinicians are hesitant to switch to an hs-cTnT assay, citing its PPV of only 70% for diagnosis of myocardial infarction (MI). They want to continue using a regular cTnT assay while using hs-cTnT as an ancillary test for risk prognosis. One respondent advises against using these two assays simultaneously because the units differ. Another respondent does not believe troponin is useful for risk prognosis. He recommends adopting hs-cTnT to rule-in/rule-out MI and using the single-value acute MI cutoffs without reporting anything lower.

Join AACC for this August 14 webinar to learn how to overcome the pitfalls of error-prone and inefficient manual inventory methods, which can disrupt workflows, burden techs, and strain a laboratory’s operating budget.